Tech Center 1600 • Art Units: 1612 1617 1621 1627 1629
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17777478 | IONIC LIQUIDS FOR DRUG DELIVERY | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18011399 | REDOX-RESPONSIVE NANOPARTICLE COMPOSITIONS FOR OCULAR DELIVERY OF THERAPEUTICS | Non-Final OA | OHIO STATE INNOVATION FOUNDATION |
| 17392837 | CONSISTENCY OF CROP YIELD THROUGH BIOLOGICAL NITROGEN FIXATION | Non-Final OA | Pivot Bio, Inc. |
| 19000196 | GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM | Non-Final OA | MEDISCA PHARMACEUTIQUE Inc. |
| 17760990 | HIGH DENSITY LIPOPROTEIN-LIKE NANOPARTICLES AS INDUCERS OF FERROPTOSIS IN CANCER | Non-Final OA | Northwestern University |
| 17975485 | COMPOSITIONS, ARTICLES, DEVICES, AND METHODS RELATED TO DROPLETS COMPRISING A CLOAKING FLUID | Non-Final OA | Massachusetts Institute of Technology |
| 17640128 | USE OF ENCAPSULATED STEROLS TO MODIFY GROWTH OF CROPS, CONTROL, AGRICULTURAL PESTS AND AS NON-TOXIC PRE-EMERGENT HERBICIDES | Non-Final OA | The Texas A&M University System |
| 19189086 | RISANKIZUMAB COMPOSITIONS | Final Rejection | ABBVIE INC. |
| 17800838 | SUPRACHOROIDAL DELIVERY OF DRUG PARTICLES TO REDUCE TOXICITY | Final Rejection | The Johns Hopkins University |
| 18025037 | Medium for Tissue for Transplantation | Non-Final OA | Riken |
| 17909601 | STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXES | Final Rejection | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17849545 | BIOMIMETIC POLYMERIC COMPOSITE FOR HEART VALVE REPAIR | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18823760 | NOVEL FORMULATION AND TREATMENT METHODS | Non-Final OA | PRODRUGXTEND PTY LTD |
| 18281381 | COSMETIC SKIN CARE COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18578843 | PHARMACEUTICAL COMPOSITIONS OF OZANIMOD | Non-Final OA | ZYDUS LIFESCIENCES LIMITED |
| 18033689 | OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT | Final Rejection | OCULAR THERAPEUTIX, INC. |
| 18018108 | Aqueous Composition | Final Rejection | Rohto Pharmaceutical Co., Ltd. |
| 18681706 | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF VISUAL DISORDERS | Final Rejection | FOODVICA, S.A. DE C.V. |
| 18294487 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERHIDROSIS | Non-Final OA | Wayne Stephen ANDREWS |
| 18576610 | ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN | Non-Final OA | HANMI PHARM. CO., LTD. |
| 18574889 | SEED UNIT COMPRISING CHARCOAL AND POLYMERIC SUPERABSORBENT | Non-Final OA | Schierbecker Handels GmbH & Co. KG |
| 18397155 | PLANT BIOLOGIC INCLUDING PYRROLOQUINOLINE QUINONE (PQQ) | Non-Final OA | Dakota Bio LLC |
| 18573953 | COMPOSITIONS AND METHODS FOR VISION IMPROVEMENT | Non-Final OA | Azura Ophthalmics Ltd. |
| 18543825 | MULTIFUNCTIONAL AGRICULTURAL ADJUVANT COMPOSITIONS | Non-Final OA | WinField Solutions, LLC |
| 18571711 | COMPOUND LIQUID FERTILIZER | Non-Final OA | Albert Nikolaevich DENISOV |
| 18007119 | LYOPHILIZED FORMULATION CONTAINING CEPHALOSPORIN HAVING CATECHOL GROUP AND THE MANUFACTURING METHOD | Final Rejection | SHIONOGI & CO., LTD. |
| 18560787 | EXTENDED-WEAR SILICONE HYDROGEL CONTACT LENSES AND USES THEREOF | Non-Final OA | OCUMEDIC, INC. |
| 18284284 | LAQUINIMOD FORMULATION FOR OCULAR USE | Final Rejection | ACTIVE BIOTECH AB |
| 18280778 | Multi-Dose Container for Ophthalmic Compositions | Non-Final OA | Vyluma Inc. |
| 18000937 | BIODEGRADABLE COMPOSITIONS AND IMPLANTS | Non-Final OA | RE-VANA THERAPEUTICS LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy